Abbvie Inc

NYSE:ABBV   10:05:40 AM EDT
+1.85 (+1.21%)

AbbVie Submits New Drug Application To FDA For Investigational ABBV-951 For Treatment Of Advanced Parkinson's Disease

Published: 05/20/2022 12:49 GMT
Abbvie Inc (ABBV) - Abbvie Submits New Drug Application to U.S. FDA for Investigational Abbv-951 (foscarbidopa/foslevodopa) for the Treatment of Advanced Parkinson's Disease.
Abbvie Inc - Will Continue to Pursue Regulatory Submissions for Abbv-951 Across International Markets Throughout Year.